Dopamine Transporter Imaging-Based Radiomics for Predicting 4-Year Motor Progression (Unified Parkinson's Disease Rating Scale Part III) in Parkinson's Disease

IF 2.4
iRadiology Pub Date : 2026-07-02 Epub Date: 2026-06-08 DOI:10.1002/ird3.70079
Xiaoxuan Fan, Yanghan Chen, Junfeng Lin, Zenwen Han, Jianqiang Ye, Lili Lin, Hong Zhang, Ang Li, Han Jiang
{"title":"Dopamine Transporter Imaging-Based Radiomics for Predicting 4-Year Motor Progression (Unified Parkinson's Disease Rating Scale Part III) in Parkinson's Disease","authors":"Xiaoxuan Fan,&nbsp;Yanghan Chen,&nbsp;Junfeng Lin,&nbsp;Zenwen Han,&nbsp;Jianqiang Ye,&nbsp;Lili Lin,&nbsp;Hong Zhang,&nbsp;Ang Li,&nbsp;Han Jiang","doi":"10.1002/ird3.70079","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Parkinson's disease (PD) shows substantial heterogeneity in motor progression, and reliable early prediction remains challenging. Dopamine transporter (DAT) imaging reflects presynaptic dopaminergic degeneration but is typically analyzed using simplified metrics that may not capture spatial heterogeneity. This study aims to evaluate whether magnetic resonance imaging (MRI)-guided DAT radiomics combined with machine learning can predict 4-year motor progression in PD.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In this retrospective study, 120 patients from the Parkinson's Progression Markers Initiative were included. Motor progression was defined using the 4-year change in Movement Disorder Society–Unified Parkinson's Disease Rating Scale part III (UPDRS-III) score. Bilateral caudate nuclei and putamina were manually delineated on T1-weighted MRI and transferred to co-registered DAT images. Radiomics features were extracted using PyRadiomics. Twenty base models were constructed by combining two feature-selection methods with 10 classifiers, and Top-2 voting fusion models were developed. Clinical-variable, levodopa equivalent daily dose (LEDD)-adjusted, and clinical-radiomics models were also evaluated.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The best-performing base model achieved a mean area under the receiver operating characteristic curve (AUROC) of 0.736. Fusion models improved discrimination, with the best soft-voting model achieving an AUROC of 0.920 and balanced accuracy (BACC) of 0.734. A more balanced fusion model achieved an AUROC of 0.902 with higher sensitivity (0.818). The clinical-radiomics model showed only a slight AUROC increase over the clinical-only model, and adding Year-4 LEDD did not materially alter radiomics performance. Stable radiomics features were predominantly texture-based, particularly gray-level co-occurrence matrix (GLCM) and gray-level run-length matrix (GLRLM) features derived from original and wavelet-filtered images.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>MRI-guided DAT radiomics combined with ensemble learning may provide prognostically relevant information for predicting 4-year motor progression in PD. Fusion strategies improved discrimination, and stable texture features may reflect striatal dopaminergic heterogeneity.</p>\n </section>\n </div>","PeriodicalId":73508,"journal":{"name":"iRadiology","volume":"4 3","pages":"246-260"},"PeriodicalIF":2.4000,"publicationDate":"2026-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ird3.70079","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"iRadiology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ird3.70079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Parkinson's disease (PD) shows substantial heterogeneity in motor progression, and reliable early prediction remains challenging. Dopamine transporter (DAT) imaging reflects presynaptic dopaminergic degeneration but is typically analyzed using simplified metrics that may not capture spatial heterogeneity. This study aims to evaluate whether magnetic resonance imaging (MRI)-guided DAT radiomics combined with machine learning can predict 4-year motor progression in PD.

Methods

In this retrospective study, 120 patients from the Parkinson's Progression Markers Initiative were included. Motor progression was defined using the 4-year change in Movement Disorder Society–Unified Parkinson's Disease Rating Scale part III (UPDRS-III) score. Bilateral caudate nuclei and putamina were manually delineated on T1-weighted MRI and transferred to co-registered DAT images. Radiomics features were extracted using PyRadiomics. Twenty base models were constructed by combining two feature-selection methods with 10 classifiers, and Top-2 voting fusion models were developed. Clinical-variable, levodopa equivalent daily dose (LEDD)-adjusted, and clinical-radiomics models were also evaluated.

Results

The best-performing base model achieved a mean area under the receiver operating characteristic curve (AUROC) of 0.736. Fusion models improved discrimination, with the best soft-voting model achieving an AUROC of 0.920 and balanced accuracy (BACC) of 0.734. A more balanced fusion model achieved an AUROC of 0.902 with higher sensitivity (0.818). The clinical-radiomics model showed only a slight AUROC increase over the clinical-only model, and adding Year-4 LEDD did not materially alter radiomics performance. Stable radiomics features were predominantly texture-based, particularly gray-level co-occurrence matrix (GLCM) and gray-level run-length matrix (GLRLM) features derived from original and wavelet-filtered images.

Conclusions

MRI-guided DAT radiomics combined with ensemble learning may provide prognostically relevant information for predicting 4-year motor progression in PD. Fusion strategies improved discrimination, and stable texture features may reflect striatal dopaminergic heterogeneity.

Abstract Image

基于多巴胺转运蛋白成像的放射组学预测帕金森病4年运动进展(统一帕金森病评定量表第三部分
帕金森氏病(PD)在运动进展中显示出实质性的异质性,可靠的早期预测仍然具有挑战性。多巴胺转运蛋白(DAT)成像反映突触前多巴胺能变性,但通常使用简化的指标进行分析,可能无法捕获空间异质性。本研究旨在评估磁共振成像(MRI)引导的DAT放射组学结合机器学习是否可以预测PD患者4年的运动进展。方法在这项回顾性研究中,纳入了120名帕金森病进展标志物倡议的患者。使用运动障碍学会统一帕金森病评定量表第三部分(UPDRS-III)评分的4年变化来定义运动进展。双侧尾状核和壳层在t1加权MRI上手工划定,并转移到共同注册的DAT图像上。使用PyRadiomics提取放射组学特征。结合两种特征选择方法和10个分类器构建了20个基模型,并开发了Top-2投票融合模型。临床变量、左旋多巴当量日剂量(LEDD)调整和临床放射组学模型也进行了评估。结果最佳基础模型的受试者工作特征曲线下平均面积(AUROC)为0.736。融合模型提高了识别能力,最佳软投票模型的AUROC为0.920,平衡精度(BACC)为0.734。更为平衡的融合模型AUROC为0.902,灵敏度更高(0.818)。临床-放射组学模型显示,与仅临床模型相比,AUROC仅略有增加,并且添加第4年LEDD并没有实质性地改变放射组学的表现。稳定的放射组学特征主要是基于纹理的,尤其是灰度共生矩阵(GLCM)和灰度游程矩阵(GLRLM)特征,这些特征来源于原始图像和小波滤波后的图像。结论mri引导的DAT放射组学结合集成学习可以为预测PD患者4年运动进展提供预后相关信息。融合策略提高了识别能力,稳定的纹理特征可能反映了纹状体多巴胺能的异质性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书